Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c mice

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 9, 2004, Pages 3591-3593

  Pal, Swati ^a   Ravindran, Rajesh ^a   Ali, Nahid ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY GLUCONATE; LIPOSOME; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; LEISHMANIA DONOVANI; LEISHMANIASIS; LIPID COMPOSITION; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHRONIC DISEASE; DRUG CARRIERS; DRUG RESISTANCE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIPOSOMES; LIVER; MICE; MICE, INBRED BALB C; PHOSPHATIDYLCHOLINES; SPLEEN;

EID: 4344673895     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.9.3591-3593.2004     Document Type: Article

References (33)

1. Afrin, F., and N. Ali. 1998. Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens. J. Parasitol. 84:743-748.
2. Alving, C. R., E. A. Steck, W. L. Chapman, Jr., V. B. Waits, L. D. Hendricks, G. M. Swartz, Jr., and W. L. Hanson. 1978. Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc. Natl. Acad. Sci. USA 75:2959-2963.
3. Aramaki, Y., K. Akiyama, T. Hara, and S. Tsuchiya. 1995. Recognition of charged liposomes by rat peritoneal and splenic macrophages: effects of fibronectin on the uptake of charged liposomes. Eur. J. Pharm. Sci. 3:63-70.
4. Baillie, A. J., T. F. Dolan, J. Alexander, and K. C. Carter. 1989. Visceral leishmaniasis in the BALB/c mouse: sodium stibogluconate treatment during acute and chronic stages of infection. Int. J. Pharm. 57:23-28.
5. Black, C. D., G. J. Watson, and R. J. Ward. 1977. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 71:550-552.
6. Carter, K. C., A. J. Baillie, J. Alexander, and T. F. Dolan. 1988. The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent. J. Pharm. Pharmacol. 40:370-373.
7. Carter, K. C., T. F. Dolan, J. Alexander, A. J. Baillie, and C. McColgan. 1989. Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice. J. Pharm. Pharmacol. 41:87-91.
8. Collins, M., K. C. Carter, and A. J. Baillie. 1992. Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate. Ann. Trop. Med. Parasitol. 86:35-40.
9. Davidson, R. N., L. di Martino, L. Gradoni, R. Giacchino, G. B. Gaeta, R. Pempinello, S. Scotti, A. Cascio, E. Castagnola, A. Maisto, M. Gramiccia, D. di Caprio, R. J. Wilkinson, and A. D. Bryceson. 1996. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin. Infect. Dis. 22:938-943.
10. Dey, T., K. Anam, F. Afrin, and N. Ali. 2000. Antileishmanial activities of stearylamine-bearing liposome. Antimicrob. Agents Chemother. 44:1739-1742.
11. Dietze, R., E. P. Milan, J. D. Berman, M. Grogl, A. Falqueto, T. F. Feitosa, K. G. Luz, F. A. Suassuna, L. A. Marinho, and G. Ksionski. 1993. Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion). Clin. Infect. Dis. 17:981-986.
12. Engwerda, C. R., M. L. Murphy, S. E. Cotterell, S. C. Smelt, and P. M. Kaye. 1998. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur. J. Immunol. 28:669-680.
13. Everlien, H., and S. Hockertz. 1999. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis. Arzneim.-Forsch. 49:954-961.
14. Filion, M. C., and N. C. Phillips. 1997. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim. Biophys. Acta 1329:345-356.
15. Frezard, F., M. S. M. Michalick, C. F. Soares, and C. Demicheli. 2000. Novel methods for the encapsulation of meglumine antimoniate into liposomes. Braz. J. Med. Biol. Res. 33:841-846.
16. Gregoriadis, G., and D. E. Neerunjun. 1974. Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. Eur. J. Biochem. 47:179-185.
17. Guru, P. Y., A. K. Agrawal, U. K. Singha, A. Singhal, and C. M. Gupta. 1989. Drug targeting in Leishmania donovani infections using tuftsin bearing liposome vehicles. FEBS Lett. 245:204-208.
18. Heath, S., M. L. Chance, and R. R. New. 1984. Quantitative and ultrastructural studies on the uptake of drug loaded liposomes by mononuclear phagocytes infected with Leishmania donovani. Mol. Biochem. Parasitol. 12:49-60.
19. Herwaldt, B. L., and J. D. Berman. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46:296-306.
20. Hsu, M. J., and R. L. Juliano. 1982. Interactions of liposomes with the reticuloendothelial system. II: nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta 720:411-419.
21. Hunter, C. A., T. F. Dolan, G. H. Coombs, and A. J. Baillie. 1988. Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J. Pharm. Pharmacol. 40:161-165.
22. Jha, T. K. 1983. Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India. Trans. R. Soc. Trop. Med. Hyg. 77:167-170.
23. Jha, T. K., Y. N. Giri, T. K. Singh, and S. Jha. 1995. Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India. Am. J. Trop. Med. Hyg. 52:536-538.
24. Juliano, R. L., and D. Stamp. 1975. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem. Biophys. Res. Commun. 63:651-658.
25. Khalil. E. A., A. M. el Hassan, E. E. Zijlstra, F. A. Hashim, M. E. Ibrahim, H. W. Ghalib, and M. S. Ali. 1998. Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Ann. Trop. Med. Parasitol. 92:151-158.
26. Mullen, A. B., A. J. Baillie, and K. C. Carter. 1998. Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B. Antimicrob. Agents Chemother. 42:2722-2725.
27. Nakanishi, T., J. Kunisawa, A. Hayashi, Y. Tsutsumi, K. Kubo, S. Nakagawa, H. Fujiwara, T. Hamaoka, and T. Mayumi. 1997. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem. Biophys. Res. Commun. 240:793-797.
28. New, R. R. C., M. L. Chance, S. C. Thomas, and W. Peters. 1978. Antileishmanial activity of antimonials entrapped in liposomes. Nature 272:55-56.
29. Prasad, L. S., and S. Sen. 1995. Migration of Leishmania donovani amastigotes in cerebrospinal fluid. Lancet 346:183-184.
30. Schwendener, R. A., P. A. Lagocki, and Y. E. Rahman. 1984. The effects of charge and size on the interaction of unilamellar liposomes with macrophages. Biochim. Biophys. Acta 772:93-101.
31. Seaman, J., C. Boer, R. Wilkinson, J. de Jong, E. de Wilde, E. Sondorp, and R. Davidson. 1995. Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clin. Infect. Dis. 21:188-193.
32. Sundar, S., N. K. Agrawal, P. R. Sinha, G. S. Horwith, and H. W. Murray. 1997. Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann. Intern. Med. 127:133-137.
33. Thakur, C. P., G. P. Sinha, A. K. Pandey, N. Kumar, P. Kumar, S. M. Hassan, S. Narain, and R. K. Roy. 1998. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as first-line drug? An observational study of 80 cases. Ann. Trop. Med. Parasitol. 92:561-569.